Caleb Neufeld
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Viral Infectious Diseases and Gene Expression in Insects
- CRISPR and Genetic Engineering
Papers in
-
- Viral Infectious Diseases and Gene Expression in Insects 6
- RNA Interference and Gene Delivery 4
- Protein Degradation and Inhibitors 2
- Oncology 7
- CAR-T cell therapy research 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Qiaobing Xu (4 shared papers)Shuo Sun (3 shared papers)Ming Wang (3 shared papers)Bernardo Pérez-Ramírez (2 shared papers)Paul W. Barone (6 shared papers)Stacy L. Springs (6 shared papers)Jacqueline M. Wolfrum (6 shared papers)Richard D. Braatz (5 shared papers)
- Journals
- Molecular Therapy — Methods & Clinical Development (2 papers)Biotechnology Advances (2 papers)Biotechnology and Bioengineering (1 paper)Journal of Immunotherapy (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Caleb Neufeld
11 papers receiving 513 citations
Peers
Comparison fields: 5 of 67
- Biomaterials 124
- Molecular Biology 354
- Genetics 121
- Biomedical Engineering 142
- Oncology 62
Countries citing papers authored by Caleb Neufeld
This map shows the geographic impact of Caleb Neufeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caleb Neufeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caleb Neufeld more than expected).
Fields of papers citing papers by Caleb Neufeld
This network shows the impact of papers produced by Caleb Neufeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caleb Neufeld. The network helps show where Caleb Neufeld may publish in the future.
Co-authors
The 25 scholars most cited alongside Caleb Neufeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 229 | |
| 2 | 2021 | 72 | |
| 3 | 2017 | 58 | |
| 4 | 2014 | 49 | |
| 5 | 2021 | 45 | |
| 6 | 2013 | 23 | |
| 7 | 2016 | 14 | |
| 8 | 2024 | 12 | |
| 9 | 2023 | 12 | |
| 10 | 2025 | 2 | |
| 11 | 2024 | 2 |
About Caleb Neufeld
Caleb Neufeld is a scholar working on Molecular Biology, Oncology, Genetics, Biomedical Engineering and Pathology and Forensic Medicine, having authored 11 papers that have together received 518 indexed citations. Recurring topics across this work include Viral Infectious Diseases and Gene Expression in Insects (6 papers), RNA Interference and Gene Delivery (4 papers), CAR-T cell therapy research (4 papers), Virus-based gene therapy research (4 papers), Protein Degradation and Inhibitors (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Mechanisms and Therapy (1 paper) and Silk-based biomaterials and applications (1 paper). The work is most often cited by research in Biomaterials (124 citations), Molecular Biology (354 citations), Genetics (121 citations), Biomedical Engineering (142 citations) and Oncology (62 citations). Caleb Neufeld has collaborated with scholars based in United States and China. Frequent co-authors include Qiaobing Xu, Shuo Sun, Ming Wang, Bernardo Pérez-Ramírez, Paul W. Barone, Stacy L. Springs, Jacqueline M. Wolfrum, Richard D. Braatz, Anthony J. Sinskey and Sha Sha. Their work appears in journals such as Molecular Therapy — Methods & Clinical Development, Biotechnology Advances, Biotechnology and Bioengineering, Journal of Immunotherapy and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.